- Home
- TTOO vs MIST Comparison
TTOO vs MIST Comparison
Compare TTOO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- MIST
- Stock Information
- Founded
- TTOO 2006
- MIST 2003
- Country
- TTOO United States
- MIST Canada
- Employees
- TTOO N/A
- MIST N/A
- Industry
- TTOO Medical/Dental Instruments
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- TTOO Health Care
- MIST Health Care
- Exchange
- TTOO Nasdaq
- MIST Nasdaq
- Market Cap
- TTOO 36.4M
- MIST 81.5M
- IPO Year
- TTOO 2014
- MIST N/A
- Fundamental
- Price
- TTOO $0.97
- MIST $1.43
- Analyst Decision
- TTOO Hold
- MIST Strong Buy
- Analyst Count
- TTOO 1
- MIST 3
- Target Price
- TTOO $5.00
- MIST $13.00
- AVG Volume (30 Days)
- TTOO 710.5K
- MIST 177.8K
- Earning Date
- TTOO 11-13-2024
- MIST 11-11-2024
- Dividend Yield
- TTOO N/A
- MIST N/A
- EPS Growth
- TTOO N/A
- MIST N/A
- EPS
- TTOO N/A
- MIST N/A
- Revenue
- TTOO $7,164,000.00
- MIST N/A
- Revenue This Year
- TTOO $50.31
- MIST N/A
- Revenue Next Year
- TTOO $117.92
- MIST N/A
- P/E Ratio
- TTOO N/A
- MIST N/A
- Revenue Growth
- TTOO N/A
- MIST N/A
- 52 Week Low
- TTOO $0.90
- MIST $1.12
- 52 Week High
- TTOO $8.38
- MIST $3.52
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- MIST 42.50
- Support Level
- TTOO $0.90
- MIST $1.41
- Resistance Level
- TTOO $1.86
- MIST $1.53
- Average True Range (ATR)
- TTOO 0.15
- MIST 0.07
- MACD
- TTOO -0.00
- MIST -0.01
- Stochastic Oscillator
- TTOO 5.72
- MIST 26.96
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).